Your browser doesn't support javascript.
loading
Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials.
Peters, Anju T; Soler, Zachary M; Kern, Robert C; Heffler, Enrico; Maspero, Jorge F; Crampette, Louis; Fujieda, Shigeharu; Lane, Andrew P; Zhang, Haixin; Nash, Scott; Khan, Asif H; Siddiqui, Shahid; Jacob-Nara, Juby A; Rowe, Paul; Deniz, Yamo.
Afiliación
  • Peters AT; Allergy-Immunology Division and the Sinus and Allergy Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Soler ZM; Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Kern RC; Department of Otolaryngology - Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Heffler E; Personalized Medicine, Asthma & Allergy - Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy.
  • Maspero JF; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Crampette L; Allergy and Respiratory Medicine, Fundación CIDEA, Buenos Aires, Argentina.
  • Fujieda S; Department of Otorhinolaryngology - Head and Neck Surgery and Maxillofacial Surgery, University Hospital of Montpellier, Montpellier, France.
  • Lane AP; Department of Otorhinolaryngology - Head/Neck Surgery, University of Fukui, Fukui, Japan.
  • Zhang H; Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Nash S; Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Khan AH; Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Siddiqui S; Global Medical Affairs, Sanofi, Chilly-Mazarin, France.
  • Jacob-Nara JA; Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Rowe P; Global Medical Affairs, Sanofi, Bridgewater, New Jersey, USA.
  • Deniz Y; Global Medical Affairs, Sanofi, Bridgewater, New Jersey, USA.
Clin Exp Allergy ; 52(9): 1105-1109, 2022 09.
Article en En | MEDLINE | ID: mdl-35775319
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sinusitis / Rinitis / Pólipos Nasales Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Exp Allergy Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sinusitis / Rinitis / Pólipos Nasales Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Exp Allergy Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos